Transnasal Aerosol Delivery via HFNC: A Question of Safety and Efficacy

Simple item page
dc.contributor.authorSaunders, Jessica L.
dc.contributor.authorDavis, Michael D.
dc.contributor.departmentPediatrics, School of Medicine
dc.date.accessioned2024-09-09T12:41:29Z
dc.date.available2024-09-09T12:41:29Z
dc.date.issued2023
dc.eprint.versionFinal published version
dc.identifier.citationSaunders JL, Davis MD. Transnasal Aerosol Delivery via HFNC: A Question of Safety and Efficacy. Respir Care. 2023;68(6):856-857. doi:10.4187/respcare.11167
dc.identifier.urihttps://hdl.handle.net/1805/43207
dc.language.isoen_US
dc.publisherDaedalus Enterprises
dc.relation.isversionof10.4187/respcare.11167
dc.relation.journalRespiratory Care
dc.rightsPublisher Policy
dc.sourcePMC
dc.subjectAerosolized medications
dc.subjectHigh-flow nasal cannula (HFNC)
dc.subjectBronchodilators
dc.titleTransnasal Aerosol Delivery via HFNC: A Question of Safety and Efficacy
dc.typeArticle
ul.alternative.fulltexthttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10208999/
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Saunders2023Transnasal-PP.pdf
Size:
33.79 KB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2.04 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Open Access Policy Articles
Department of Pediatrics Works